Medical device manufacturing combines technical complexity with one of the most demanding regulatory documentation environments in any industry. ISO 13485:2016 and FDA 21 CFR Part 820 require comprehensive quality management systems where every design decision, supplier qualification, nonconformance, corrective action, and post-market signal is documented and retrievable. For a company with a 10–50 person quality and regulatory affairs team, sustaining these records while simultaneously supporting product development and regulatory submissions is a perpetual capacity challenge.
Virtual assistants with medical device QMS familiarity are providing practical administrative leverage—handling the coordination, tracking, and documentation logistics that occupy quality engineers and regulatory affairs professionals without requiring their technical expertise.
Design History File Coordination
The Design History File—required under 21 CFR 820.30(j)—is the organized collection of records describing the design history of a finished device. DHF documents include design inputs, design outputs, design reviews, verification and validation protocols and reports, risk management files, and design transfer records.
Coordinating DHF completeness across a product development program requires tracking which documents exist, which are pending review, which need revision, and which must be generated before a design phase can close. A virtual assistant managing DHF coordination can:
- Maintain the DHF index against the product development phase checklist
- Route documents for review and approval signatures
- Track outstanding documentation items against project milestones
- Compile DHF packages for notified body technical file submissions
The regulatory engineer decides what the documents must say; the VA ensures the file is complete and organized.
CAPA Evidence Collection and Tracking
Corrective and Preventive Actions under ISO 13485 Clause 8.5.2 require documented root cause analysis, corrective action implementation, effectiveness verification, and record retention. The failure mode that most commonly generates FDA 483 observations is not inadequate root cause analysis—it is inadequate documentation of the analysis and the verification evidence.
A VA managing CAPA coordination can collect evidence as it is generated: gathering inspection data supporting root cause, logging implementation records as actions are completed, collecting effectiveness verification data, and updating the CAPA tracker status. Quality engineers review the technical substance; the VA ensures the evidence file is complete.
According to FDA's 2024 inspection database analysis, CAPA-related observations accounted for 29% of all medical device quality system 483s—the single most cited clause area.
Supplier Audit Scheduling and Documentation
ISO 13485 Clause 7.4 requires documented supplier qualification and re-evaluation based on risk. For critical suppliers, this typically includes on-site or remote audits with audit reports filed in the supplier quality file. Scheduling these audits against the annual supplier surveillance plan, coordinating logistics with suppliers, distributing audit checklists, and filing completed audit reports are all administrative tasks that fall to the supplier quality engineer.
A VA can own the supplier audit calendar: scheduling audit dates against the surveillance plan, sending advance notifications and pre-audit questionnaires, following up for completed preparation packages, and filing audit reports with CAR issuance tracking when findings require response.
Post-Market Surveillance Documentation
ISO 13485 Clause 8.2.1 and EU MDR Article 83 require systematic post-market surveillance—collection and analysis of field data, complaint records, literature monitoring, and registry data to evaluate ongoing safety and performance. For smaller device companies, maintaining the PMS documentation file current is a continuous administrative task.
A VA supporting PMS documentation can log incoming complaint records, track complaint investigation due dates, file literature monitoring searches by review date, and maintain the PMS summary report document with updated data inputs.
Manufacturers ready to build sustainable QMS administrative capacity can explore medical device VAs at Stealth Agents.
Sources
- Medical Device and Diagnostic Industry (MDDI), Quality Team Capacity Survey, 2024
- FDA, CAPA 483 Observation Analysis, 2024
- ISO 13485:2016, Clauses 7.4, 8.2.1, 8.5.2
- 21 CFR Part 820.30(j)